14.07.2009 11:00:00

Henry Schein Becomes Exclusive Distributor for Dentatus Narrow Body Implants in North America, Australia and New Zealand

Henry Schein, Inc., (NASDAQ:HSIC) the largest distributor of healthcare products and services to office-based practitioners, and Dentatus, an innovative designer and manufacturer of precision high-tech dental products, today announced a five-year agreement establishing Henry Schein as the exclusive distributor of the Dentatus Atlas narrow body implant system in North America, Australia and New Zealand. Through this agreement, Henry Schein will now be able to offer dental practitioners the full breadth of dental implants.

"In this important and growing market, the Dentatus Atlas system stands apart and is distinctly different from other systems, with clear benefits that shorten healing time and increase patient comfort,” said Stanley Bergman, Chairman and Chief Executive Officer of Henry Schein. "In North America alone, we estimate the edentulous population who could benefit from this technology to be approximately 50 million people, with projected six million new edentulous patients per year. We look forward to working closely with Dentatus to offer these important new products to our North American, Australian and New Zealand dental customers.”

The Dentatus Atlas implants surrounded with the Tuf-Link Resilient Denture liner provides secure retention and cushioned patient comfort. The implant low profile eliminates the need to drastically reduce the denture, and its small diameter allows placement where significant bone loss has occurred without bone augmentation. The Atlas flapless surgical procedure, which is significantly less expensive than a conventional implant procedure, shortens healing time and reduces discomfort. The procedure requires no surgical incision and no sutures—both of which are typical for wider, more conventional implants—and it can be performed using only local anesthesia in the office of a patient’s general dentist in only 45-60 minutes. The patient can walk out of the office wearing their refitted denture right away.

With Dentatus Atlas implants, denture wearers of any age can experience healthier and better looking smiles with comfortable and fully functioning dentures. After undergoing the procedure, patients are able to keep their dentures in place while sleeping, brush them in the morning and treat them like natural teeth. Dentures can be easily removed and reseated without any stress. Patients are able to laugh, smile, maintain a nutritious diet and eat their favorite foods with confidence. Dentatus Atlas implants provide patients with substantial relief from the pain and discomfort they previously endured with ill-fitting dentures, while stimulating the jawbone so less bone is lost. Dentures fit more comfortably and properly support facial features that may have been previously lost, enhancing a patient’s self esteem.

"In Henry Schein, we believe that we have found a sophisticated distribution partner that can compellingly communicate the significant benefits of the Dentatus Atlas system to dental practitioners,” said Bernard Weissman, President of Dentatus USA. "The company’s track record of success in growing technology-driven products is impressive, and we look forward to a close collaboration that will strengthen the position of this innovative implant system in these important markets.”

About Dentatus

Dentatus, founded in 1930 for the purpose of serving the then-emerging Scandinavian dental market, is renowned for its line of precision semi-adjustable articulators that are in continuous use in many universities and dental teaching facilities throughout the world. To an even greater extent the company is known for its preeminent posture of having introduced the first prefabricated classic posts used in dentistry. The broad range of Dentatus Surtex surface-treated classic posts in titanium, stainless steel, and gold-plated continues to enjoy a dominant market position in many international markets and is recognized as the standard in dentistry. Presently, an expanded line consisting of Luminex light-transmitting posts and the more recently introduced fiberglass light-transmitting Luscent and Twin Luscent Anchors, largely used with aesthetic adhesive materials, satisfies the full range of needs in the broad spectrum of restorative procedures.

Bernard Weissman, the founder and former owner of Whaledent International, acquired Dentatus AB, located in Stockholm, Sweden in 1988. Dentatus USA, Ltd, located in New York, N.Y., was founded in 1989, serving as a distribution center for all Dentatus products sold in North and South America. With the acquisition of Dentatus AB, the company expanded its marketing strategies and accelerated the development of products for the 21st century to satisfy dentistry’s modern needs. Mr. Weissman’s 18 most recent patented inventions, introduced incrementally into the market, provide Dentatus group with a continuous stream of innovative and proprietary products. Among these are the highly regarded Profin® Reciprocating Handpiece and the assorted line of Lamineer Tips®. All other products are used in the specialty fields of prosthodontics, endodontics, and periodontics.

About Henry Schein

Henry Schein, a Fortune 500® company and a member of the Nasdaq 100® Index, is recognized for its excellent customer service and highly competitive prices. The Company's four business groups – Dental, Medical, International and Technology – serve more than 575,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items. Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.

Headquartered in Melville, N.Y., Henry Schein employs more than 12,500 people and has operations or affiliates in 23 countries. The Company's net sales reached a record $6.4 billion in 2008. For more information, visit the Henry Schein Web site at www.henryschein.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Henry Schein Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Henry Schein Inc. 73,54 0,30% Henry Schein Inc.

Indizes in diesem Artikel

NASDAQ Comp. 19 060,48 -0,60%
NASDAQ 100 20 744,49 -0,85%